6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986–2020

      research-article
      1 , , 2 , 3
      BMC Public Health
      BioMed Central
      Breast cancer, Prostate cancer, Mortality, Trends, Screening, Lithuania

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Breast cancer (BC) and prostate cancer (PC) mortality rates in Lithuania remain comparatively high despite the ongoing BC and PC screening programmes established in 2006. The aim of this study was to investigate time trends in BC and PC mortality rates in Lithuania evaluating the effects of age, calendar period of death, and birth-cohort over a 35-year time span.

          Methods

          We obtained death certification data for BC in women and PC in men for Lithuania during the period 1986–2020 from the World Health Organisation database. Age-standardised mortality rates were analysed using Joinpoint regression. Age-period-cohort models were used to assess the independent age, period and cohort effects on the observed mortality trends.

          Results

          Joinpoint regression analysis indicated that BC mortality increased by 1.6% annually until 1996, and decreased by − 1.2% annually thereafter. The age-period-cohort analysis suggests that temporal trends in BC mortality rates could be attributed mainly to cohort effects. The cohort effect curvature showed the risk of BC death increased in women born prior to 1921, remained stable in cohorts born around 1921–1951 then decreased; however, trend reversed in more recent generations. The period effect curvature displayed a continuous decrease in BC mortality since 1991–1995. For PC mortality, after a sharp increase by 3.0%, rates declined from 2007 by − 1.7% annually. The period effect was predominant in PC mortality, the curvature displaying a sharp increase until 2001–2005, then decrease.

          Conclusions

          Modestly declining recent trends in BC and PC mortality are consistent with the introduction of widespread mammography and PSA testing, respectively, lagging up to 10 years. The study did not show that screening programme introduction played a key role in BC mortality trends in Lithuania. Screening may have contributed to favourable recent changes in PC mortality rates in Lithuania, however the effect was moderate and limited to age groups < 65 years. Further improvements in early detection methods followed by timely appropriate treatment are essential for decreasing mortality from BC and PC.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12889-022-14207-4.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

          Europe contains 9% of the world population but has a 25% share of the global cancer burden. Up-to-date cancer statistics in Europe are key to cancer planning. Cancer incidence and mortality estimates for 25 major cancers are presented for the 40 countries in the four United Nations-defined areas of Europe and for Europe and the European Union (EU-28) for 2018.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates

            Previous studies have reported significant variation in prostate cancer rates and trends mainly due to differences in detection practices, availability of treatment, and underlying genetic susceptibility.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              International variation in prostate cancer incidence and mortality rates.

              Wide variation exists internationally for prostate cancer (PCa) rates due to differences in detection practices, treatment, and lifestyle and genetic factors. We present contemporary variations in PCa incidence and mortality patterns across five continents using the most recent data from the International Agency for Research on Cancer. PCa incidence and mortality estimates for 2008 from GLOBOCAN are presented. We also examine recent trends in PCa incidence rates for 40 countries and mortality rates for 53 countries from 1985 and onward via join-point analyses using an augmented version of Cancer Incidence in Five Continents and the World Health Organization mortality database. Estimated PCa incidence rates remain most elevated in the highest resource counties worldwide including North America, Oceania, and western and northern Europe. Mortality rates tend to be higher in less developed regions of the world including parts of South America, the Caribbean, and sub-Saharan Africa. Increasing PCa incidence rates during the most recent decade were observed in 32 of the 40 countries examined, whereas trends tended to stabilize in 8 countries. In contrast, PCa mortality rates decreased in 27 of the 53 countries under study, whereas rates increased in 16 and remained stable in 10 countries. PCa incidence rates increased in nearly all countries considered in this analysis except in a few high-income countries. In contrast, the increase in PCa mortality rates mainly occurred in lower resource settings, with declines largely confined to high-resource countries. Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                ruta.everatt@nvi.lt
                Journal
                BMC Public Health
                BMC Public Health
                BMC Public Health
                BioMed Central (London )
                1471-2458
                23 September 2022
                23 September 2022
                2022
                : 22
                : 1812
                Affiliations
                [1 ]GRID grid.459837.4, ISNI 0000 0000 9826 8822, Laboratory of Cancer Epidemiology, , National Cancer Institute, ; Baublio 3B, LT-08406 Vilnius, Lithuania
                [2 ]GRID grid.6441.7, ISNI 0000 0001 2243 2806, Department of Plastic and Reconstructive Surgery, , Vilnius University Hospital Santaros Klinikos, ; Vilnius, Lithuania
                [3 ]GRID grid.459837.4, ISNI 0000 0000 9826 8822, Breast Surgery and Oncology Department, , National Cancer Institute, ; Vilnius, Lithuania
                Article
                14207
                10.1186/s12889-022-14207-4
                9508783
                36151551
                dfea13b4-5f92-466c-8d2d-34f0fc6f9cb0
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 9 May 2022
                : 12 September 2022
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Public health
                breast cancer,prostate cancer,mortality,trends,screening,lithuania
                Public health
                breast cancer, prostate cancer, mortality, trends, screening, lithuania

                Comments

                Comment on this article